Penserra Capital Management LLC Twist Bioscience Corp Transaction History

Penserra Capital Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$27.95 - $53.0 $531,776 - $1.01 Million	19,026 New	19,026 $938,000
Q2 2022 Aug 15, 2022	SELL	$26.2 - $54.0 $1,886 - $3,888	-72 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$38.58 - $83.27 $2,777 - $5,995	72 New	72 $3,000
Q4 2021 Feb 15, 2022	SELL	$75.47 - $135.88 $85,281 - $153,544	-1,130 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$95.64 - $131.48 $1,434 - $1,972	15 Added 1.35%	1,130 $120,000
Q2 2021 Aug 12, 2021	BUY	$88.13 - $142.06 $1,321 - $2,130	15 Added 1.36%	1,115 $148,000
Q1 2021 May 13, 2021	BUY	$105.48 - $207.97 $6,328 - $12,478	60 Added 5.77%	1,100 $136,000
Q4 2020 Feb 12, 2021	BUY	$76.64 - $167.89 $50,429 - $110,471	658 Added 172.25%	1,040 $146,000
Q3 2020 Nov 13, 2020	BUY	$45.46 - $78.79 $17,365 - $30,097	382 New	382 $29,000

255

66.9M

127K

45.4K

Ticker TWST
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 56,363,500
Market Cap $2.95B
Description
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for d...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.